What the business is, and whether it's a good one at a fair price.
Makes and sells chemical products through its Non-Textile Segment, which generated ₹27.58 crore in FY26, or 85.7% of segment revenue. The smaller Textile Segment contributed ₹4.62 crore, or 14.3% of segment revenue, in the same period. For FY26 as a whole, the company reported total income of ₹3,219.52 lakhs, down from ₹3,914.45 lakhs in the prior year, while profit after tax rose to ₹252.63 lakhs from ₹214.74 lakhs on lower raw material consumption. Raw materials are the dominant cost, accounting for 57.7% of revenue, followed by other operating expenses at 29.1% and employee costs at 14.2%. The Non-Textile Segment was also the more profitable, with EBIT of ₹2.20 crore versus ₹0.38 crore in the Textile Segment. The business is small-scale, with total assets of ₹43.26 crore at FY26 and operations based in Ahmedabad, Gujarat.
Measured from the filed financials, judged against its Specialty Chemicals peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from ARVEE LABORATORIES I LTD's filed financials and exchange disclosures
ARVEE LABORATORIES I LTD is a Chemicals & Petrochemicals company listed on NSE, trading under the symbol ARVEE.
Yes. Over the trailing twelve months ARVEE LABORATORIES I LTD reported a net profit of ₹4 Cr on revenue of ₹41 Cr.
Not in the latest reported year — ARVEE LABORATORIES I LTD's dividend payout for FY26 was nil.
Effectively yes. Debt stands at 0.03× equity.
On trailing P/E, ARVEE LABORATORIES I LTD ranks 80 of 103 in Specialty Chemicals — cheaper than 23% of them, against an industry median of 23.4×. This is a position, not a valuation judgement.
On a typical session ARVEE LABORATORIES I LTD moves 1.90% — that is the median absolute close-to-close move across its last 265 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by ARVEE LABORATORIES I LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
